MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings announces the establishment of a pro-bono support program geared at furthering ultra-rare illness research.

FREMONT, CA: MMS Holdings Inc., an award-winning, data-driven CRO, has announced the establishment of a pro-bono support program geared at furthering ultra-rare illness research. MMS will choose patient advocacy groups with a demonstrated need for this program and offer complimentary regulatory help.

The MMS team and the organization's skills are well-suited to this assistance program. Most of the rare diseases are ultra-rare conditions, which necessitate different methods within the same regulatory framework. When negotiating the laws, guidelines, and general regulatory requirements that regulate the documentation proving of a drug's safety and efficacy, an experienced partner can provide significant insight and answers.

MMS recognizes the value of a tailored regulatory strategy as well as the hurdles that these programs encounter. MMS has funded rare disease initiatives for more than a decade, from early-stage research to licensure for use in more than 12 therapeutic categories, and it embraces the opportunity to promote other rare disease programs.

"We are proud to have built a program that affords patients and families with ultra-rare diseases the opportunity to move closer to effective therapies," said Dr. Uma Sharma, Chief Scientific Officer and Founder, MMS. "Many of our colleagues come into this field with an altruistic focus - to help others. This program will provide a new perspective on radically new technologies and therapies that may never have made it to the licensing stage and is set to help improve the lives of many."

MMS will form an advisory board comprised of regulatory strategy and writing specialists, other industry thought leaders, and pharma or biotech Sponsor contributors involved in project selection, review participation, and strategic feedback.

"This program was brought to fruition by a colleague who recommended it as a better way to use pre-allocated volunteer hours," said Alan Nicolle, Senior Director, European & South African Operations. "People like this who lead change make MMS a best place to work for those with an innovation-first, Sense of Urgency and Leadership (SOUL) mindset."